Synonym
AGLME; N-alpha-Acetylglycyllysyl methyl ester;
IUPAC/Chemical Name
methyl acetylglycyl-L-lysinate
InChi Key
FIGKGJVUYAFLBI-VIFPVBQESA-N
InChi Code
InChI=1S/C11H21N3O4/c1-8(15)13-7-10(16)14-9(11(17)18-2)5-3-4-6-12/h9H,3-7,12H2,1-2H3,(H,13,15)(H,14,16)/t9-/m0/s1
SMILES Code
O=C(C)NCC(N[C@@H](CCCCN)C(OC)=O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
259.30
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Capet-Antonini FC, Tamenasse J. Kinetic studies on soluble and insoluble urokinases. Can J Biochem. 1975 Aug;53(8):890-4. PubMed PMID: 241473.
2: Walker JE, Campbell DM, Ogston D. Inhibitors of fibrinolysis in amniotic fluid. Thromb Haemost. 1980 Aug 29;44(1):32-4. PubMed PMID: 6968460.
3: Fräki JE, Hopsu-Havu VK. Human skin proteases. Fractionation of psoriasis scale proteases and separation of a plasminogen activator and a histone hydrolysing protease. Arch Dermatol Res. 1976 Aug 27;256(2):113-26. PubMed PMID: 9031.
4: Ong EB, Soberano ME, Johnson AJ, Dharmgrongartama ED. The plasminogen activator and esterase activities of the two forms of urokinase. Thromb Res. 1981 Nov 1;24(3):223-32. PubMed PMID: 7038974.
5: Baker A, Zídek L, Wiesler D, Chmelík J, Pagel M, Novotny MV. Reaction of N-acetylglycyllysine methyl ester with 2-alkenals: an alternative model for covalent modification of proteins. Chem Res Toxicol. 1998 Jul;11(7):730-40. PubMed PMID: 9671535.
6: Baker AG, Wiesler D, Novotny MV. Tandem mass spectrometry of model peptides modified with trans-2-hexenal, a product of lipid peroxidation. J Am Soc Mass Spectrom. 1999 Jul;10(7):613-24. PubMed PMID: 10384725.
7: Nobuhara M, Sakamaki M, Ohnishi H, Suzuki Y. A comparative study of high molecular weight urokinase and low molecular weight urokinase. J Biochem. 1981 Jul;90(1):225-32. PubMed PMID: 7026550.
8: DeCaprio AP, Spink DC, Chen X, Fowke JH, Zhu M, Bank S. Characterization of isothiocyanates, thioureas, and other lysine adduction products in carbon disulfide-treated peptides and protein. Chem Res Toxicol. 1992 Jul-Aug;5(4):496-504. PubMed PMID: 1391615.
9: Niinobe M, Hitomi Y, Fujii S. A sensitive colorimetric assay for various proteases using naphthyl ester derivatives as substrates. J Biochem. 1980 Mar;87(3):779-83. PubMed PMID: 6446549.
10: Kondo M, Gigli I, Austen KF. Fluid phase destruction of C2 hu by C1 hu. 3. Changes in activity for synthetic substrates upon cell binding, heat inactivation and interaction with C1INH. Immunology. 1972 Mar;22(3):305-18. PubMed PMID: 5063623; PubMed Central PMCID: PMC1407812.
11: Henson PM, Oades ZG. Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF-induced secretion. J Exp Med. 1976 Apr 1;143(4):953-68. PubMed PMID: 3619; PubMed Central PMCID: PMC2190161.
